ADR Biomedical Holdings (TSE:3750) Total Current Assets: 円350.51 Mil (As of Mar. 2026)

What is ADR Biomedical Holdings Total Current Assets?

ADR Biomedical Holdings TSE:3750 +0.37% 30 Total Current Assets is 円350.51 Mil as of Mar. 2026. GuruFocus rates TSE:3750 with a GF Score™ of 30/100 and a GF Value™ of 円40.38 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. ADR Biomedical Holdings's total current assets for the quarter that ended in Mar. 2026 was 円350.51 Mil.

ADR Biomedical Holdings (TSE:3750) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

ADR Biomedical Holdings's Liquidation Value for the quarter that ended in Mar. 2026 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	125.901	-	346.032	+	0.75 * 8.188	+	0.5 * 66.41
=	-180.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ADR Biomedical Holdings Total Current Assets Related Terms

ADR Biomedical Holdings Total Current Assets Historical Data

* Premium members only.

The historical data trend for ADR Biomedical Holdings's Total Current Assets can be seen below:

ADR Biomedical Holdings Total Current Assets Chart

ADR Biomedical Holdings Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

Total Current Assets

Get a 7-Day Free Trial

3,029.16

1,388.20

1,427.68

517.16

350.51

ADR Biomedical Holdings Semi-Annual Data
	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25	Sep25	Mar26
Total Current Assets	Get a 7-Day Free Trial															1,427.68	796.47	517.16	574.21	350.51

30GF Score

ADR Biomedical Holdings Inc TSE:3750

Total Current Assets is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

ADR Biomedical Holdings Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

ADR Biomedical Holdings's Total Current Assets for the fiscal year that ended in Mar. 2026 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	125.901	+	148.881	+	66.41	+	9.317
	=	350.51

ADR Biomedical Holdings's Total Current Assets for the quarter that ended in Mar. 2026 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	125.901	+	148.881	+	66.41	+	9.317
	=	350.51

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Frequently Asked Questions Learn more about Total Current Assets →

What does a Total Current Assets of 円350.51 Mil mean?

ADR Biomedical Holdings (TSE:3750) has a Total Current Assets of 円350.51 Mil as of Mar. 2026. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for ADR Biomedical Holdings and its competitors.

Is ADR Biomedical Holdings' Total Current Assets too high?

ADR Biomedical Holdings' current Total Current Assets is 円350.51 Mil. Overall, ADR Biomedical Holdings has a GF Score™ of 30/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does ADR Biomedical Holdings' Total Current Assets compare to VRTX and REGN?

ADR Biomedical Holdings' Total Current Assets of 円350.51 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Current Assets for a Biotechnology company?

A good Total Current Assets depends on the Biotechnology industry context. However, Total Current Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Current Assets mean?

A high Total Current Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets with liquidity less than one year as recorded on a company's balance sheet. View historical data for ADR Biomedical Holdings and its competitors. ADR Biomedical Holdings's current Total Current Assets is 円350.51 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is ADR Biomedical Holdings stock overvalued right now?

Based on GuruFocus' analysis, ADR Biomedical Holdings (TSE:3750) is currently considered Significantly Overvalued. The stock's GF Value™ is 円40.38, compared to a current price of 円808.00 — trading 1901% above its estimated fair value. The current Total Current Assets is 円350.51 Mil. ADR Biomedical Holdings' overall GF Score™ is 30/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Current Assets calculated?

Total Current Assets is calculated from a company's financial statements. For ADR Biomedical Holdings (TSE:3750), the current Total Current Assets is 円350.51 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ADR Biomedical Holdings (TSE:3750) Overvalued in 2026?

Based on GuruFocus' analysis, ADR Biomedical Holdings stock appears to be overvalued. The current stock price of 円808.00 is trading 1901% above its estimated GF Value™ of 円40.38. GuruFocus considers ADR Biomedical Holdings to be Significantly Overvalued.

Key valuation signals for TSE:3750:

Total Current Assets: 円350.51 Mil
GF Value™: 円40.38 vs. price of 円808.00 (1901% above fair value)
GF Score™: 30/100 with 9 warning signs

No single metric tells the full story. See the TSE:3750 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ADR Biomedical Holdings Business Description

Industry Healthcare Biotechnology

Comparable Companies TSE:4584 TSE:7096 TSE:2370 TSE:2385 TSE:4594 TSE:4564 TSE:4880 TSE:4572 TSE:7776 TSE:4596 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004

Website https://www.cytori.co.jp

ADR120S Inc developing a new clinical approach to cell therapy to provide medical care to patients by providing medical care that responds to unmet medical needs based on its regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.

30GF Score

Get the complete analysis for TSE:3750

Total Current Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円808.00

Price

円40.38

GF Value

View TSE:3750 Analysis

See Total Current Assets data for all stocks →